The pharmaceutical sector has been a love-hate relationship recently. Looking at the stocks I hold, like 3SBio and Innovent Biologics, there's constant fundamental news, but the market performance remains sluggish. On the other hand, WuXi Biologics surged sharply today, making me hesitant to chase—who knows if it's just a rebound or a reversal. WuXi AppTec seems to experience minor fluctuations whenever there's new drug anticipation, without major volatility. Giant Biotech barely moves when cosmetic medicine topics arise, even playfully dipping downward. The overall spring season for pharmaceuticals sees many traders but a very indifferent atmosphere—neither rising nor falling much, just a phase testing patience.